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During February 2004–September 2006, familial clus-
ters and sporadic cases of Staphylococcus aureus skin and 
soft tissue infections were observed in a suburban area 
near Milan in northern Italy. Molecular typing of the iso-
lates showed an epidemic methicillin-susceptible S. aureus 
(MSSA) strain, spa type 005 and sequence type 22 that har-
bored Panton-Valentine leukocidin (PVL) genes. The ﬁ  rst 
case-patients were neonates or mothers who had recently 
delivered in the local hospital. Examination of the medical 
records showed a cluster of postpartum mastitis and neo-
natal skin infections antedating the emergence of infections 
in the community. Nasal swabs of neonates, mothers, and 
hospital staff were positive for the epidemic MSSA. Hospital 
circulation of the strain was interrupted by implementation 
of infection control measures, although infections continued 
to occur in the community. The PVL-positive MSSA strain 
resembles typical community-acquired methicillin-resistant 
S. aureus in its ability to cause prolonged community and 
hospital outbreaks of skin infections.
L
ong established as a hospital pathogen, methicillin-
resistant  Staphylococcus aureus (MRSA) is now 
present in the community as a major cause of skin and 
soft tissue infections (1). In the United States the commu-
nity-acquired (CA)–MRSA clone designated USA300 has 
been identiﬁ  ed in almost 50% of community-onset skin 
infections (2). In Europe, CA-MRSA infections appear to 
be less common than in the United States, although inci-
dence is increasing (3,4) and CA-MRSA strains are more 
genetically diverse (5). 
Characteristically, most CA-MRSA strains contain 
Panton-Valentine leukocidin (PVL) genes, a bicomponent 
pore-forming toxin with the ability to lyse leukocytes (6), 
primarily associated with skin infections such as furuncu-
losis and skin abscesses (7). Although clinicians are cur-
rently concerned primarily with CA-MRSA infections, 
methicillin-susceptible S. aureus (MSSA) infections can 
present with similar epidemiologic and clinical character-
istics (8,9). In addition, the presence of PVL genes is not 
limited to MRSA nor is their presence a recent occurrence. 
Historical MSSA isolates, such as the “Oxford Staphylo-
coccus” and phage type 80/81 strains that were pandemic in 
the 1950s and 1960s harbor PVL genes (10,11). Recently, 
PVL-positive MSSA strains have been associated with out-
breaks of skin infections in Swiss schoolchildren (12), in a 
village in Germany (13), and in French soldiers operating 
in Côte d’Ivoire (14). According to a large multinational 
clinical trial, conducted outside the United States, PVL-
positive S. aureus isolates are more likely to be MSSA than 
MRSA (15). The epidemiology of PVL-positive MSSA is 
not well known and the pathogenic potential is probably 
underestimated.
This report describes a large and prolonged commu-
nity and hospital outbreak of skin and soft tissue infections 
caused by a PVL-positive MSSA strain. In a number of 
characteristics, the outbreak closely resembles outbreaks 
associated with CA-MRSA. 
Methods
Setting of the Community Outbreak
During February 2004–September 2006, several fam-
ily clusters of skin and soft tissue infections were observed 
in a suburban area south of Milan in northern Italy. The 
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patients lived in or near the town of Codogno and sought 
treatment at the outpatient clinic of the local hospital. In 
each of the family clusters, the ﬁ  rst identiﬁ  ed case was a 
newborn child or a mother who had recently delivered in 
the Codogno Hospital. In 2006, another cluster of skin and 
soft tissue infections was observed in young patients who 
lived in different households in the same suburban area.
Setting of the Hospital Outbreak
Medical records and microbiologic data regarding skin 
and soft tissue infections occurring in neonates or moth-
ers examined in the Codogno Hospital from 2003 through 
2005 were reviewed. At the time of the review, the hospital 
was a 220-bed facility, serving a community of ≈15,000 
inhabitants. The maternity ward comprised 7 rooms with a 
total of 13 beds and was part of the Department of Obstet-
rics and Gynecology. The department had 45 staff mem-
bers that included obstetricians, midwives, nurses, and sup-
port staff. Annually, ≈600 deliveries were performed. The 
newborn nursery was under the direction of the Department 
of Pediatrics and included 2 rooms, 1 room for changing 
and feeding the babies and the other room with 14 cribs for 
the neonates. The nursery staff included 9 neonatal nurses 
and 1 general nurse, but 16 additional staff members were 
shared across the Department of Pediatrics. The median 
length of stay of neonates in the nursery was 4 days. A 
follow-up visit was performed at a dedicated hospital clinic 
10–15 days after discharge. 
Microbiologic and Molecular Typing Methods
Bacteriologic specimens were obtained for culture 
from the largest infected body area with a sterile swab or 
needle and were processed in the microbiology laboratory 
of the Codogno Hospital according to standard methods. 
Swabs obtained from anterior nares were plated directly 
onto salt mannitol agar plates and blood agar plates without 
a preenrichment step. Plates were incubated for 24 h in am-
bient air and 5% CO2, respectively. Identiﬁ  cation of isolates 
and antimicrobial susceptibility tests were performed with 
an automatic system (Vitek 2; bioMérieux, Marcy l’Etoile, 
France). The susceptibility pattern was conﬁ  rmed by the 
disk-diffusion method following Clinical and Laboratory 
Standards Institute guidelines (16). 
Further molecular tests and genotyping were per-
formed on all S. aureus isolates that had been stored. Bac-
terial DNA was prepared with a commercial kit (QIAamp 
DNA Mini Kit; QIAGEN GmbH, Hilden, Germany). Spe-
cies identiﬁ  cation and methicillin susceptibility were con-
ﬁ  rmed by a duplex PCR assay with primers targeting nuc 
and mecA genes, respectively. Detection of the presence of 
the genes lukS-PV and lukF-PV coding for the 2 subunits of 
the PVL toxin was obtained by PCR (17).
To analyze clonal relatedness of the strains, all avail-
able isolates were submitted to pulsed-ﬁ  eld gel electropho-
resis (PFGE) and to a sequence-based method that detects 
variations in the short sequence repeat (SSR) region of the 
protein A gene (spa typing) (18). For PFGE, total genomic 
DNA embedded in agarose plugs was digested with SmaI 
and separated by using a previously described method (19). 
Proﬁ  les of strains that differed by fewer than 3 bands were 
considered to belong to the same PFGE type (20). For spa 
typing, PCR ampliﬁ  cation of the SSR region was performed 
according to the protocol of Shopsin et al. (18). Sequences 
were obtained and analyzed by using an Internet-based 
software Ridom Staph Type (www.ridom.de/spaserver). 
Selected isolates underwent multilocus sequence typing 
(MLST) according to the recommended method (21). The 
allelic proﬁ  les obtained were compared with those depos-
ited in the MLST database (http://saureus.mlst.net).
Screening for S. aureus Carriage
To ascertain the spread of S. aureus in the maternity 
ward and nursery of the hospital, we performed screening 
for S. aureus nasal colonization on neonates, mothers, and 
medical and nonmedical staff who worked in the Depart-
ments of Pediatrics and Obstetrics and Gynecology. Two 
separate surveys were performed, the ﬁ  rst in July 2005 and 
the second in December 2005, after implementation of en-
hanced infection control measures. 
Results 
Skin and Soft Tissue Infections in the Community
Five familial clusters of skin and soft tissue infec-
tions, involving 2–5 family members, were observed in the 
Codogno area. The ﬁ  rst case in each cluster occurred in 
2004 or early 2005, but infections in other household mem-
bers or recurrent infections continued to be observed until 
2006. In all families, the onset of infection was associated 
with a neonate born in the Codogno Hospital or a mother 
who had recently delivered in the same hospital.
Furunculosis and abscesses were the most common 
clinical features and relapses were common (Table 1). Fu-
runculosis of the prepuce developed in a neonate in family 
1 four days after birth in the Codogno Hospital in February 
2004. His father sought treatment for recurrent subcutane-
ous axillary abscesses later in 2004 and in 2005, and a leg 
abscess developed in his mother in September 2006.
The mother in family 2 sought treatment for an infec-
tion in the vulva, groin, and inner thighs in August 2004, 
ten days after delivering at the Codogno Hospital. Several 
recurrences of abscesses in the same areas occurred as well 
as in this patient’s left buttock and leg until 2006. In 2005, 
furunculosis developed in the father on his nose and scalp, 
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and recurring pustules developed on the inner thighs of 2 
siblings over 2 months.
In family 3, a subcutaneous facial abscess developed 
in the mother in January 2005, two months after she de-
livered at the Codogno Hospital; subsequently, a vulvar 
abscess and recurrent abscesses of the right leg continued 
to develop in this patient until 2006. The child had a leg 
abscess in June 2006.
Family cluster 4 involved 5 persons: a neonate, a sib-
ling, both parents, and the maternal grandmother. Pustules 
developed on the neck and groin of the neonate 4 days after 
birth at the Codogno Hospital in January 2005 and sub-
sequently, subcutaneous abscesses developed in the axilla 
and forearm. Over the same time multiple subcutaneous 
abscesses developed in the axillae and on the forearms and 
legs of both parents and the elder sibling. The grandmother 
had a facial abscess in July 2005, and the father contracted 
furunculosis of the left forearm in September 2006.
Family cluster 5 involved both parents of a child who 
was born in the Codogno Hospital in December 2004 but 
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Table 1. Characteristics of patients with community-acquired MSSA skin and soft tissue infections, their treatment, and molecular
typing of the isolates, northern Italy, 2004–2006* 
Molecular typing of MSSA isolates
Patient Age, sex Site of infection†
Type of 
infection†
Antimicrobial
drug
treatment† Drainage
Presence of 
PVL genes
PFGE 
type
spa
type ST
Family clusters
Cluster 1
P 1 32 y, F Leg Abscess None Spontaneous NA
P 2 33 y, M Axilla Abscesses AMC, CIP None NA
P 3 4 d, M Prepuce Pustules GEN None NA
Cluster 2
P 4 30 y, F Vulva, thighs Pustules,
abscesses
AMC, LFX, 
TEC
None + A t005 22
P 5 33 y, M Nose, scalp Pustules AMC None NA
P 6 14 mo, F Thigh Pustules CLI None NA
P 7 14 d, F Thigh Pustules CLI None + A t005 ND
Cluster 3
P 8 32 y, F Face, vulva, leg Abscesses AMC, CIP, 
LFX
None + A t005 22
P 9 25 mo, F Leg Abscess None Spontaneous NA
Cluster 4
P 10 34 y, F Axilla, forearm, leg Abscesses AMC None NA
P 11 35 y, M Axilla, forearm, leg Abscess,
furuncles
AMC, LFX Surgical + A t005 ND
P 12 4 d, M Neck, groin, axilla, Pustules,
abscesses
AMC, AMC Spontaneous + A t005 22
P 13 3 y, M Forearm Abscesses AMC None NA
P 14 65 y, F Axilla, forearm, leg, 
face
Abscess None None NA
Cluster 5
P 15 33 y, F Face, leg, axilla Pustules,
abscess
AMC Surgical NA
P 16 36 y, M Thigh Furuncles,
abscess
AMC None NA
Sporadic cases
P 17 64 y, F Axilla Abscess CIP None + A t005 22
P 18 7 mo, F Arm Pustules AMC None – F t159 ND
P 19 9 y, F Axilla Furuncles AMC None – F t159 ND
P 20 12 mo, M Groin Abscess AMC None + A t005 ND
P 21 8 y, F Leg Abscess AMC None – G t445 ND
P 22 18 mo, M Forearm Furuncles AMC None + A t005 ND
P 23 12 mo, F Buttock Abscess AMC Spontaneous + A t005 ND
P 24 20 mo, F Thigh Abscess AMC None + A t005 22
P 25 8 y, M Arm, chest Abscesses AMC Surgical + A t005 ND
P 26 11 y, M Face, eye Abscess,
conjunctivitis
AMC None + A t005 22
*MSSA, methicillin-susceptible Staphylococcus aureus; PVL, Panton-Valentine leukocidin; PFGE, pulsed-field gel electrophoresis; ST, sequence type; NA, 
isolate not available; AMC, amoxicillin-clavulanic acid; CIP, ciprofloxacin; GEN, gentamicin (topical); LFX, levofloxacin; TEC, teicoplanin; CLI, clindamycin 
(topical); ND, not determined. 
†When >1 site or type of infection or antibimicrobial agents are indicated, they refer to different infection episodes.  Skin and Soft Tissue Infections, Northern Italy
who did not experience skin infections. Facial pustules de-
veloped in the mother in February 2005, two months post-
partum. Subsequently, she was treated for a leg abscess 
and axillary furunculosis. In March 2006, a subcutaneous 
abscess developed in the thigh of her husband in March 
2006.
All cases with a bacteriologic diagnosis were caused 
by MSSA that showed a distinct susceptibility pattern: 
resistant to penicillin and gentamicin and susceptible to 
oxacillin, erythromycin, tetracycline, rifampicin, and cip-
roﬂ  oxacin. Nasal swabs were performed in 7 patients from 
the clusters and were positive for MSSA in 6.
During March–June 2006, eleven additional cases of 
S. aureus skin and soft tissue infections occurred in patients 
who lived in the same area in different households and who 
were not related to the family clusters. With the exception 
of a case caused by CA-MRSA/ST8 in an infant 3 years of 
age (22), the other 10 cases were caused by MSSA. Nine 
patients were children ranging in age from 6 months to 11 
years. Two infants (Table 1, patients 20 and 23) had ex-
perienced a pustular rash 1 year earlier, soon after birth in 
the Codogno Hospital. Clinical signs included pustulosis 
or furunculosis (3 patients) and abscesses (7 patients). One 
patient also had conjunctivitis. Patients were neither immu-
nosuppressed nor had preexisting skin infections or other 
risk factors. 
Antimicrobial drugs, mostly oral amoxicillin-clavu-
lanic acid, were given to patients based on their clinical 
conditions and site and size of the infected area (23) (Table 
1). A recurrence of a large subcutaneous abscess in 1 adult 
patient led to treatment with intravenous teicoplanin. Spon-
taneous drainage occurred in 4 abscesses, and surgical inci-
sion and drainage were performed in 3 cases. All patients 
had a favorable outcome. 
Molecular Typing of Isolates from 
Community Infections
Isolates available for molecular typing included 5 
MSSA from family clusters 2, 3, and 4, and 10 MSSA from 
the sporadic cases in 2006. All isolates from the family 
clusters and 7 of the 10 isolates from the sporadic cases 
contained PVL genes. By PFGE, all PVL-positive isolates 
appeared indistinguishable or closely related (differing by 
1–2 bands) and were assigned to PFGE type A. These iso-
lates also exhibited an identical spa type, corresponding to 
t005. MLST of 6 representative isolates yielded sequence 
type (ST) 22 (Table 1). Isolates with these characteristics 
will be subsequently referred to as the “epidemic MSSA 
clone.” Three PVL-negative MSSA isolates, obtained from 
infections in 2006, showed different PFGE, spa, and MLST 
types (Table 1).
Skin and Soft Tissue Infections in 
Mothers and Neonates
Examination of medical records and microbiologic 
data from the Codogno Hospital showed a cluster of post-
partum mastitis involving 13 women that had occurred 
from October 2003 through January 2004, before the fam-
ily clusters were identiﬁ  ed. The women had delivered in 
the same hospital 2–12 weeks before the onset of symp-
toms. In 6 case-patients, mastitis had progressed to breast 
abscesses and required surgical drainage. Culture of the 
drainage yielded MRSA in 1 case-patient and MSSA in 
the other case-patients. MSSA isolates had a susceptibility 
pattern identical to that of the community-acquired MSSA. 
Molecular studies were not performed on these isolates.
In early 2004, several cases of skin infections (mainly 
pustulosis of the groin or upper thigh) were observed in 
neonates in the hospital nursery or after discharge when 
they were examined during routine follow-up visits. From 
January through March 2004, 14 such skin infections were 
observed. No other cases were identiﬁ  ed until December 
2004, when 9 cases occurred. From January through Sep-
tember 2005, skin infections developed in a total of 65 neo-
nates, with peak incidence in June and July when 14 and 
17 cases were identiﬁ  ed, respectively. In July 2005, screen-
ing for nasal S. aureus carriage was initiated, and infec-
tion control measures were enforced (see Infection Control 
Measures). Cases of infection gradually diminished, and 
no new cases were observed after September 2005. MSSA 
isolates were obtained from all neonates whose specimens 
had been cultured with skin infections in 2004 and 2005, 
but the isolates were not stored and were not available for 
molecular studies.
Screening for S. aureus Carriage and 
Molecular Typing of Carriage MSSA Isolates
To ascertain the circulation of S. aureus in the Codog-
no Hospital, screening for S. aureus nasal carriage was per-
formed in the maternity ward and the nursery in July 2005 
and in December 2005, after implementation of infection 
control measures. In July 2005, nasal swabs were obtained 
from 48 neonates, 58 mothers, and 71 medical and non-
medical personnel. MSSA was isolated from 19 (39.6%) 
of 48 neonates in the nursery, 16 (27.6%) of 58  mothers, 
and 19  (26.8%) of 71 staff (Table 2). No MRSA strain was 
identiﬁ  ed. Remarkably, all of the 17 available isolates from 
neonates were PVL-positive and 16 corresponded to the 
epidemic MSSA clone. Only 1 maternal and 3 staff isolates 
corresponded to the epidemic MSSA clone. Personnel col-
onized with the epidemic MSSA included 1 pediatrician, 1 
newborn nurse, and 1 nurse in the Department of Obstetrics 
and Gynecology. One of the neonates was colonized by a 
PVL-positive MSSA that had a PFGE proﬁ  le, spa type, 
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and MLST that were completely different from those of the 
epidemic MSSA. MSSA isolates that were PVL-negative 
were genotypically heterogeneous, showing a number of 
different PFGE proﬁ  les and spa types (data not shown). 
In the December 2005 screening, nasal swabs were 
obtained from 43 neonates, 17 mothers, and 64 staff. No 
neonate was colonized with S. aureus, although 5 (29.4%) 
of 17 mothers and 4 (6.2%) of 64 staff members carried 
MSSA. In addition, a staff member was colonized with 
MRSA. Only 1 isolate from a mother corresponded to the 
epidemic PVL-positive MSSA clone, which suggests that 
although transmission inside the nursery had been inter-
rupted, the epidemic strain was still circulating in the com-
munity. Two pediatric nurses were colonized by PVL-pos-
itive MSSA isolates that showed PFGE types, spa types, 
and STs that were unrelated to the outbreak MSSA clone 
(Table 2). 
In all cases but 1, results of spa typing were in accor-
dance with the PFGE analysis, by clustering the isolates 
belonging to the epidemic clone and discriminating geneti-
cally different isolates. The exception was a PVL-positive 
MSSA isolate obtained from a neonatal nurse in the July 
screening. This isolate was PFGE type A that had a novel 
spa type (t2336) resulting from deletion of 4 of the 12 re-
peats of t005, and yielded a novel combination of MLST 
alleles (ST954) that was a single locus variant of ST 22. 
Infection Control Measures
When the neonatal outbreak of skin infections was 
identiﬁ   ed in December 2004, contact precautions were 
instituted in the nursery and the maternity ward for staff 
and mothers, who were required to wear a gown and mask 
when feeding their babies. In June 2005, these control mea-
sures were expanded to include enhanced contact precau-
tions based on existing recommendations to control the 
spread of MRSA and other drug-resistant microorganisms 
(24). Notices to promote handwashing among personnel 
as well as among mothers and visitors were posted on the 
walls of the nursery and waiting areas. The nursery and ad-
jacent areas were deeply cleaned with chlorine-containing 
disinfectant. After nasal carriage screening in July 2005, 
intranasal mupirocin was administered to all neonates and 
was continued until hospital discharge, usually for 5 days. 
Personnel and mothers with MSSA-positive nasal cultures 
received nasal mupirocin for 5 days with or without a 3-day 
course of amoxicillin/clavulanate. After the introduction of 
these measures, cases of MSSA skin infections in neonates 
decreased and no new cases occurred in the hospital after 
September 2005, no infections were reported at follow-up 
visits, and no neonates in the nursery carried S. aureus in 
the December 2005 nasal screening.
Discussion
We have described a large and prolonged outbreak 
caused by a PVL-positive MSSA strain that was probably 
initiated in the maternity ward and nursery of the local hos-
pital and spread to the community. Striking similarities exist 
between the principal features of this outbreak and recent 
descriptions of outbreaks caused by typical CA-MRSA. 
First, skin infections occurred predominantly in children 
and young adults without risk factors, with intrafamilial 
spread and recurrences (several examples of familial trans-
mission of CA-MRSA have been described in which family 
members can serve as a reservoir of CA-MRSA) (25,26). 
Second, the epidemic MSSA clone was prolonged in the 
community (in northern Denmark, a CA-MRSA strain was 
responsible for a community outbreak of recurring infec-
tions that involved 46 persons >6 years of age) (27). Third, a 
mastitis outbreak occurred and neonatal infections emerged 
in the local hospital (an outbreak of CA-MRSA infections 
in a neonatal intensive care unit was likely initiated by the 
mother of the index case who had a CA-MRSA wound in-
fection and mastitis) (28). Twenty-one percent of neonates 
with CA-MRSA infections at the Texas Children’s Hospi-
tal had a mother with a history of skin infections, including 
mastitis and axillary abscesses (29).
Our study has some clear limitations because the PVL-
positive MSSA outbreak strain was only demonstrated in 
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Table 2. Results of nasal carriage screenings and molecular typing of PVL-positive MSSA isolates, northern Italy, 2005* 
MSSA isolates  PVL-positive isolates 
Persons sampled (no.) 
MSSA carriers, 
no. (%)  No. examined  No. PVL+  PFGE type (no. isolates)  spa type  ST
July 
  Neonates (48)  19 (39.6)  17 17 A (16)  t005 22
B (1) t021 956
  Mothers (55)  16 (27.6)  10 1 A (1)  t005 22
  Staff (71)  19 (26.8)  17 4 A (3)  t005 22
A (1) t2336 954
December
 Neonates  (43)  0 0 0
  Mothers (17)  5 (29.4)  3 1 A (1)  t005 22
  Staff (64)  3 (4.7)  3 2 D (1)  t645 1210
E (1) t1445 1209
*PVL, Panton-Valentine leukocidin; MSSA, methicillin-susceptible Staphylococcus aureus; PFGE, pulsed-field gel electrophoresis; ST, sequence type.  Skin and Soft Tissue Infections, Northern Italy
isolates from 3 family clusters, in community infections in 
2006, and in the hospital carriers. That the epidemic clone 
was responsible for the other 2 family clusters and the post-
partum mastitis outbreak can only be inferred from the re-
cords of isolation of MSSA with a distinctive susceptibility 
pattern (i.e., resistant to penicillin and gentamicin only). As 
for infections in neonates, these were generally considered 
mild, and microbiologic cultures were performed in only a 
few cases. In addition to the microbiologic ﬁ  ndings, epide-
miologic and clinical data support the presence of an unusu-
ally virulent strain. In the Codogno Hospital outbreak, the 
temporal relationship between the mastitis outbreak and the 
emergence of neonatal MSSA infections suggests that the 
source of the strain might have been a mother who had un-
detected infection or colonization at delivery and transmit-
ted the strain to the baby. Subsequently, the strain spread 
inside the newborn nursery, possibly with the contribution 
of colonized healthcare workers, leading to the colonization 
of babies and the emergence of skin infections a few days 
after birth. The colonized/infected mothers and neonates in 
turn spread the MSSA strain in the community. 
Implementation of infection control measures, in-
cluding enhanced hand hygiene, contact precautions, and 
mupirocin treatment, resulted in a rapid decline in the oc-
currence of neonatal infections and the disappearance of 
the strain among neonatal carriers. There are no established 
data to support prophylactic treatment with mupirocin in 
MSSA-colonized patients, although its use has been pro-
posed for some colonized at-risk patients who will undergo 
surgery (30). Despite control in the hospital, skin infections 
caused by the epidemic MSSA clone continued in family 
clusters, and new cases unrelated to family clusters were 
recognized in 2006. In the family clusters, hygienic mea-
sures were suggested to avoid spread to other family mem-
bers, but decolonization with mupirocin was not attempted. 
Two recent reports highlight the efﬁ  cacy of mupirocin de-
colonization to terminate outbreaks of skin infections in the 
community (12,13). 
Since June 2006, only 2 new cases caused by the epi-
demic MSSA strain were observed in 2 adult men in the 
community, 1 in 2007 and the other in 2008, indicating that 
the outbreak was controlled but that the strain had not dis-
appeared from the community. In addition, in July 2007, 
the father in family cluster 1 experienced a recurrence of 
a chest abscess caused by the epidemic MSSA strain. Al-
though no earlier isolate from that family was studied, the 
same epidemic strain was likely responsible for skin infec-
tions in that family over the span of at least 3 years. 
The PVL-positive outbreak MSSA strain, character-
ized by t005 and ST22, is related to one of the major MRSA 
clones circulating in hospitals in the United Kingdom, 
where it has been designated EMRSA-15 (31). Although 
this clone, also known as ST22-IV, harbors the type IV 
staphylococcal cassette chromosome mec (SCCmec) and is 
uncommon in the United States (32), it is now emerging 
as a successful clone in several areas of the world (33,34). 
Characteristically EMRSA-15 is susceptible to gentamicin 
and resistant to erythromycin and ciproﬂ  oxacin (34).
Clonal group ST22 includes MRSA as well as MSSA 
(35), both of which can contain PVL genes. Recently, a 
PVL-positive ST22 MRSA strain caused a large outbreak 
in Bavaria (36). This strain was susceptible to most non–β-
lactam antimicrobial agents, including erythromycin and 
ciproﬂ  oxacin. The MSSA strain responsible for the out-
break in northern Italy was susceptible to erythromycin and 
ciproﬂ  oxacin and resistant to gentamicin, resulting in a sus-
ceptibility proﬁ  le highly divergent from that of EMRSA-
15. The epidemic MSSA clone could represent the ancestor 
of a hospital MRSA clone or, less likely, a derivative of a 
hospital MRSA clone that emerged by deletion of SCCmec. 
Whichever is the case, PVL genes have been introduced 
into a genetic background associated with the ability to 
spread rapidly and cause epidemics.
The role of PVL in the pathogenesis of S. aureus infec-
tions is still controversial. Animal models of necrotizing 
pneumonia provide conﬂ  icting results (37,38). In a mouse 
model of skin infections, PVL did not seem to play an in-
dispensable role (39). However, it is difﬁ  cult to dismiss the 
simple observation that S. aureus isolates causing skin in-
fections in humans are enriched for PVL (40). This is more 
striking in Europe, where PVL is associated with a variety 
of different S. aureus genotypes (5) and not with a single 
major clone as in the United States (2). Hypothetically, 
PVL could play a role that has not been explored in animal 
models, e.g., to enhance persistence in nasal colonization or 
survival on the skin. Alternatively, the PVL bacteriophage 
could confer other properties to S. aureus that contribute to 
the pathogenesis of skin infections. 
The presence of PVL or the PVL bacteriophage may 
contribute to some of the characteristics of this clone that 
are shared with typical CA-MRSA, including its ability to 
persist in the human reservoir, to cause skin infections in 
healthy young persons, and to require enhanced infection 
control precautions in the hospital. The only distinctive dif-
ference with CA-MRSA infections is the wider spectrum 
of therapeutic options available that includes β-lactam anti-
microbial agents. On the other hand, the hospital and com-
munity outbreaks were initially overlooked because the 
causative agent of the infections was an MSSA strain. This 
study underscores how the overall genetic background of 
the S. aureus strain and not the methicillin resistance trait 
per se, determines clinical severity and the epidemiologic 
features of infections.
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